Etiology, Epidemiology and Treatment of Diarrhea and Enterocolitis in Hemato-oncological High Risk Patients (EpiDi)
Recruiting
- Conditions
- Haematologic malignancy
- Registration Number
- DRKS00000111
- Lead Sponsor
- niklinik Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Neutropenia >= 5 days, defined as <500 neutrophils/microL. If no differential blood count available, use <1000 leukocytes/micro
Exclusion Criteria
a)Neutropenia <5 days, defined as <500 neutrophils/microL. If no differential blood count available, use <1000 leukocytes/microL
b)Patients with Colitis ulcerosa, Morbus Crohn or other inflammatory diseases of the colon
c)Patients with diarrhea at admission
d)Patienten, receiving prophylaxis with metronidazole (per os or intravenous) or vancomycin (per os)
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of abdominal complications after chemotherapy
- Secondary Outcome Measures
Name Time Method Effect of empiric metronidazole or vancomycin on the incidence of abdominal complications